secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2024-07-16T23:59:59+00:00
Accession:  0001213900-24-061853
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharma shareholders approve 1:5-1:12 reverse split and 5M share increase
--------------------------------------------------------------------------------

- All five director nominees elected; each received >3.6M votes for.
- Amendment to 2022 Equity Plan approved: 5M new shares authorized for issuance.
- Reverse stock split authorized at ratio between 1:5 to 1:12, effective date to be set by board.
- Modification of CEO/CFO option strike price and consultant option issuance both approved to comply with Nasdaq listing rules.
- Ratification of RBSM LLP as independent auditor for FY2024 approved with 6.2M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024061853/0001213900-24-061853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024061853/ea0209525-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-061853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer